nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprindine—CALM2—semen—testicular cancer	0.206	0.222	CbGeAlD
Aprindine—CALM1—semen—testicular cancer	0.205	0.221	CbGeAlD
Aprindine—CALM3—seminal vesicle—testicular cancer	0.0556	0.06	CbGeAlD
Aprindine—CALM2—embryo—testicular cancer	0.0465	0.0502	CbGeAlD
Aprindine—CALM1—embryo—testicular cancer	0.0463	0.0499	CbGeAlD
Aprindine—CALM2—seminal vesicle—testicular cancer	0.0437	0.0471	CbGeAlD
Aprindine—CALM3—female gonad—testicular cancer	0.0326	0.0352	CbGeAlD
Aprindine—CALM2—gonad—testicular cancer	0.0315	0.034	CbGeAlD
Aprindine—CALM1—gonad—testicular cancer	0.0314	0.0339	CbGeAlD
Aprindine—CALM3—testis—testicular cancer	0.029	0.0312	CbGeAlD
Aprindine—CALM2—female gonad—testicular cancer	0.0256	0.0277	CbGeAlD
Aprindine—CALM1—female gonad—testicular cancer	0.0255	0.0275	CbGeAlD
Aprindine—CALM2—testis—testicular cancer	0.0227	0.0245	CbGeAlD
Aprindine—CALM1—testis—testicular cancer	0.0226	0.0244	CbGeAlD
Aprindine—ORM1—lymph node—testicular cancer	0.0222	0.0239	CbGeAlD
Aprindine—CALM3—lymph node—testicular cancer	0.021	0.0226	CbGeAlD
Aprindine—CALM2—lymph node—testicular cancer	0.0165	0.0178	CbGeAlD
Aprindine—CALM1—lymph node—testicular cancer	0.0164	0.0177	CbGeAlD
Aprindine—CYP2D6—female gonad—testicular cancer	0.0142	0.0153	CbGeAlD
Aprindine—CYP2D6—testis—testicular cancer	0.0126	0.0136	CbGeAlD
Aprindine—SCN5A—Developmental Biology—PRDM14—testicular cancer	0.00222	0.0302	CbGpPWpGaD
Aprindine—SCN5A—Cardiac Progenitor Differentiation—KIT—testicular cancer	0.0018	0.0245	CbGpPWpGaD
Aprindine—CALM3—BCR signaling pathway—BCL10—testicular cancer	0.00158	0.0215	CbGpPWpGaD
Aprindine—CALM1—BCR signaling pathway—BCL10—testicular cancer	0.00153	0.0208	CbGpPWpGaD
Aprindine—CALM2—BCR signaling pathway—BCL10—testicular cancer	0.00153	0.0208	CbGpPWpGaD
Aprindine—CALM3—Phospholipase C-mediated cascade—FGFR3—testicular cancer	0.000816	0.0111	CbGpPWpGaD
Aprindine—CALM2—Phospholipase C-mediated cascade—FGFR3—testicular cancer	0.00079	0.0108	CbGpPWpGaD
Aprindine—CALM1—Phospholipase C-mediated cascade—FGFR3—testicular cancer	0.00079	0.0108	CbGpPWpGaD
Aprindine—CALM3—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000725	0.00989	CbGpPWpGaD
Aprindine—CALM2—Endochondral Ossification—FGFR3—testicular cancer	0.00071	0.00967	CbGpPWpGaD
Aprindine—CALM1—Endochondral Ossification—FGFR3—testicular cancer	0.00071	0.00967	CbGpPWpGaD
Aprindine—CALM2—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000702	0.00956	CbGpPWpGaD
Aprindine—CALM1—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000702	0.00956	CbGpPWpGaD
Aprindine—CALM3—B Cell Activation—BCL10—testicular cancer	0.000671	0.00915	CbGpPWpGaD
Aprindine—CALM1—B Cell Activation—BCL10—testicular cancer	0.000649	0.00885	CbGpPWpGaD
Aprindine—CALM2—B Cell Activation—BCL10—testicular cancer	0.000649	0.00885	CbGpPWpGaD
Aprindine—CALM3—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.000502	0.00684	CbGpPWpGaD
Aprindine—CALM2—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.000486	0.00662	CbGpPWpGaD
Aprindine—CALM1—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.000486	0.00662	CbGpPWpGaD
Aprindine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	0.000475	0.00648	CbGpPWpGaD
Aprindine—CALM3—Downstream signal transduction—KITLG—testicular cancer	0.000472	0.00643	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR—KITLG—testicular cancer	0.000469	0.0064	CbGpPWpGaD
Aprindine—CALM3—Signaling by ERBB2—KITLG—testicular cancer	0.000467	0.00637	CbGpPWpGaD
Aprindine—CALM3—DAP12 signaling—KITLG—testicular cancer	0.000465	0.00634	CbGpPWpGaD
Aprindine—CALM1—Downstream signal transduction—KITLG—testicular cancer	0.000456	0.00622	CbGpPWpGaD
Aprindine—CALM2—Downstream signal transduction—KITLG—testicular cancer	0.000456	0.00622	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR—KITLG—testicular cancer	0.000454	0.00619	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR—KITLG—testicular cancer	0.000454	0.00619	CbGpPWpGaD
Aprindine—CALM2—Signaling by ERBB2—KITLG—testicular cancer	0.000452	0.00616	CbGpPWpGaD
Aprindine—CALM1—Signaling by ERBB2—KITLG—testicular cancer	0.000452	0.00616	CbGpPWpGaD
Aprindine—CALM2—DAP12 signaling—KITLG—testicular cancer	0.00045	0.00613	CbGpPWpGaD
Aprindine—CALM1—DAP12 signaling—KITLG—testicular cancer	0.00045	0.00613	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR in disease—KITLG—testicular cancer	0.000437	0.00596	CbGpPWpGaD
Aprindine—CALM3—DAP12 interactions—KITLG—testicular cancer	0.000437	0.00596	CbGpPWpGaD
Aprindine—CALM3—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000437	0.00596	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR—KITLG—testicular cancer	0.000433	0.00591	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.00043	0.00586	CbGpPWpGaD
Aprindine—CALM3—Signaling by PDGF—KITLG—testicular cancer	0.000428	0.00583	CbGpPWpGaD
Aprindine—CALM2—DAP12 interactions—KITLG—testicular cancer	0.000423	0.00577	CbGpPWpGaD
Aprindine—CALM1—DAP12 interactions—KITLG—testicular cancer	0.000423	0.00577	CbGpPWpGaD
Aprindine—CALM1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000423	0.00577	CbGpPWpGaD
Aprindine—CALM2—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000423	0.00577	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR in disease—KITLG—testicular cancer	0.000423	0.00577	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR in disease—KITLG—testicular cancer	0.000423	0.00577	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR—KITLG—testicular cancer	0.000419	0.00572	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR—KITLG—testicular cancer	0.000419	0.00572	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000416	0.00566	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000416	0.00566	CbGpPWpGaD
Aprindine—CALM2—Signaling by PDGF—KITLG—testicular cancer	0.000414	0.00564	CbGpPWpGaD
Aprindine—CALM1—Signaling by PDGF—KITLG—testicular cancer	0.000414	0.00564	CbGpPWpGaD
Aprindine—CALM3—B Cell Activation—KITLG—testicular cancer	0.000405	0.00552	CbGpPWpGaD
Aprindine—CALM1—B Cell Activation—KITLG—testicular cancer	0.000392	0.00534	CbGpPWpGaD
Aprindine—CALM2—B Cell Activation—KITLG—testicular cancer	0.000392	0.00534	CbGpPWpGaD
Aprindine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.00039	0.00531	CbGpPWpGaD
Aprindine—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000387	0.00528	CbGpPWpGaD
Aprindine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000377	0.00514	CbGpPWpGaD
Aprindine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000377	0.00514	CbGpPWpGaD
Aprindine—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000375	0.00511	CbGpPWpGaD
Aprindine—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000375	0.00511	CbGpPWpGaD
Aprindine—SCN5A—Axon guidance—MMP2—testicular cancer	0.000374	0.0051	CbGpPWpGaD
Aprindine—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000373	0.00509	CbGpPWpGaD
Aprindine—CALM3—Signaling by GPCR—INSL3—testicular cancer	0.000368	0.00501	CbGpPWpGaD
Aprindine—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000362	0.00493	CbGpPWpGaD
Aprindine—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000361	0.00492	CbGpPWpGaD
Aprindine—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000361	0.00492	CbGpPWpGaD
Aprindine—CALM1—Signaling by GPCR—INSL3—testicular cancer	0.000356	0.00485	CbGpPWpGaD
Aprindine—CALM2—Signaling by GPCR—INSL3—testicular cancer	0.000356	0.00485	CbGpPWpGaD
Aprindine—CALM3—Downstream signal transduction—FGFR3—testicular cancer	0.000351	0.00478	CbGpPWpGaD
Aprindine—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.00035	0.00477	CbGpPWpGaD
Aprindine—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.00035	0.00477	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR—FGFR3—testicular cancer	0.000349	0.00476	CbGpPWpGaD
Aprindine—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	0.000347	0.00473	CbGpPWpGaD
Aprindine—CALM3—DAP12 signaling—FGFR3—testicular cancer	0.000346	0.00471	CbGpPWpGaD
Aprindine—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000343	0.00467	CbGpPWpGaD
Aprindine—CALM2—Downstream signal transduction—FGFR3—testicular cancer	0.000339	0.00462	CbGpPWpGaD
Aprindine—CALM1—Downstream signal transduction—FGFR3—testicular cancer	0.000339	0.00462	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR—FGFR3—testicular cancer	0.000338	0.0046	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR—FGFR3—testicular cancer	0.000338	0.0046	CbGpPWpGaD
Aprindine—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	0.000336	0.00458	CbGpPWpGaD
Aprindine—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	0.000336	0.00458	CbGpPWpGaD
Aprindine—CALM1—DAP12 signaling—FGFR3—testicular cancer	0.000334	0.00456	CbGpPWpGaD
Aprindine—CALM2—DAP12 signaling—FGFR3—testicular cancer	0.000334	0.00456	CbGpPWpGaD
Aprindine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000331	0.00452	CbGpPWpGaD
Aprindine—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000331	0.00452	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000325	0.00443	CbGpPWpGaD
Aprindine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000325	0.00443	CbGpPWpGaD
Aprindine—CALM3—DAP12 interactions—FGFR3—testicular cancer	0.000325	0.00443	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	0.000322	0.00439	CbGpPWpGaD
Aprindine—CALM3—Downstream signal transduction—KIT—testicular cancer	0.000322	0.00439	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR—KIT—testicular cancer	0.00032	0.00437	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000319	0.00435	CbGpPWpGaD
Aprindine—CALM3—Signaling by ERBB2—KIT—testicular cancer	0.000319	0.00435	CbGpPWpGaD
Aprindine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	0.000318	0.00433	CbGpPWpGaD
Aprindine—CALM3—DAP12 signaling—KIT—testicular cancer	0.000317	0.00432	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000314	0.00429	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000314	0.00429	CbGpPWpGaD
Aprindine—CALM2—DAP12 interactions—FGFR3—testicular cancer	0.000314	0.00429	CbGpPWpGaD
Aprindine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000314	0.00429	CbGpPWpGaD
Aprindine—CALM1—DAP12 interactions—FGFR3—testicular cancer	0.000314	0.00429	CbGpPWpGaD
Aprindine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000314	0.00429	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	0.000312	0.00425	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	0.000312	0.00425	CbGpPWpGaD
Aprindine—CALM2—Downstream signal transduction—KIT—testicular cancer	0.000311	0.00425	CbGpPWpGaD
Aprindine—CALM1—Downstream signal transduction—KIT—testicular cancer	0.000311	0.00425	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR—KIT—testicular cancer	0.00031	0.00422	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR—KIT—testicular cancer	0.00031	0.00422	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000309	0.00421	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000309	0.00421	CbGpPWpGaD
Aprindine—CALM1—Signaling by ERBB2—KIT—testicular cancer	0.000308	0.0042	CbGpPWpGaD
Aprindine—CALM2—Signaling by ERBB2—KIT—testicular cancer	0.000308	0.0042	CbGpPWpGaD
Aprindine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	0.000308	0.00419	CbGpPWpGaD
Aprindine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	0.000308	0.00419	CbGpPWpGaD
Aprindine—CALM1—DAP12 signaling—KIT—testicular cancer	0.000307	0.00418	CbGpPWpGaD
Aprindine—CALM2—DAP12 signaling—KIT—testicular cancer	0.000307	0.00418	CbGpPWpGaD
Aprindine—CALM3—B Cell Activation—FGFR3—testicular cancer	0.000301	0.0041	CbGpPWpGaD
Aprindine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000298	0.00407	CbGpPWpGaD
Aprindine—CALM3—DAP12 interactions—KIT—testicular cancer	0.000298	0.00407	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	0.000298	0.00407	CbGpPWpGaD
Aprindine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	0.000298	0.00407	CbGpPWpGaD
Aprindine—CALM3—Signaling by NGF—KITLG—testicular cancer	0.000298	0.00406	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR—KIT—testicular cancer	0.000296	0.00403	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000293	0.004	CbGpPWpGaD
Aprindine—CALM3—Signaling by PDGF—KIT—testicular cancer	0.000292	0.00398	CbGpPWpGaD
Aprindine—CALM2—B Cell Activation—FGFR3—testicular cancer	0.000291	0.00397	CbGpPWpGaD
Aprindine—CALM1—B Cell Activation—FGFR3—testicular cancer	0.000291	0.00397	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	0.000289	0.00394	CbGpPWpGaD
Aprindine—CALM2—DAP12 interactions—KIT—testicular cancer	0.000289	0.00394	CbGpPWpGaD
Aprindine—CALM1—DAP12 interactions—KIT—testicular cancer	0.000289	0.00394	CbGpPWpGaD
Aprindine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000289	0.00394	CbGpPWpGaD
Aprindine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000289	0.00394	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	0.000289	0.00394	CbGpPWpGaD
Aprindine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	0.000289	0.00393	CbGpPWpGaD
Aprindine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	0.000289	0.00393	CbGpPWpGaD
Aprindine—CALM1—Signaling by NGF—KITLG—testicular cancer	0.000288	0.00393	CbGpPWpGaD
Aprindine—CALM2—Signaling by NGF—KITLG—testicular cancer	0.000288	0.00393	CbGpPWpGaD
Aprindine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000288	0.00392	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR—KIT—testicular cancer	0.000286	0.0039	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR—KIT—testicular cancer	0.000286	0.0039	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000284	0.00387	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000284	0.00387	CbGpPWpGaD
Aprindine—CALM2—Signaling by PDGF—KIT—testicular cancer	0.000282	0.00385	CbGpPWpGaD
Aprindine—CALM1—Signaling by PDGF—KIT—testicular cancer	0.000282	0.00385	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—BCL10—testicular cancer	0.000282	0.00384	CbGpPWpGaD
Aprindine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000279	0.0038	CbGpPWpGaD
Aprindine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000279	0.0038	CbGpPWpGaD
Aprindine—CALM3—B Cell Activation—KIT—testicular cancer	0.000276	0.00376	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—BCL10—testicular cancer	0.000273	0.00372	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—BCL10—testicular cancer	0.000273	0.00372	CbGpPWpGaD
Aprindine—CALM3—Adaptive Immune System—BCL10—testicular cancer	0.000271	0.00369	CbGpPWpGaD
Aprindine—CALM1—B Cell Activation—KIT—testicular cancer	0.000267	0.00364	CbGpPWpGaD
Aprindine—CALM2—B Cell Activation—KIT—testicular cancer	0.000267	0.00364	CbGpPWpGaD
Aprindine—SCN5A—Developmental Biology—MMP2—testicular cancer	0.000267	0.00364	CbGpPWpGaD
Aprindine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000264	0.0036	CbGpPWpGaD
Aprindine—CALM2—Adaptive Immune System—BCL10—testicular cancer	0.000262	0.00357	CbGpPWpGaD
Aprindine—CALM1—Adaptive Immune System—BCL10—testicular cancer	0.000262	0.00357	CbGpPWpGaD
Aprindine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000256	0.00349	CbGpPWpGaD
Aprindine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000256	0.00349	CbGpPWpGaD
Aprindine—CALM3—Signaling by NGF—FGFR3—testicular cancer	0.000221	0.00302	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—INSL3—testicular cancer	0.000217	0.00296	CbGpPWpGaD
Aprindine—CALM1—Signaling by NGF—FGFR3—testicular cancer	0.000214	0.00292	CbGpPWpGaD
Aprindine—CALM2—Signaling by NGF—FGFR3—testicular cancer	0.000214	0.00292	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—INSL3—testicular cancer	0.00021	0.00287	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—INSL3—testicular cancer	0.00021	0.00287	CbGpPWpGaD
Aprindine—CALM3—Signaling by NGF—KIT—testicular cancer	0.000203	0.00277	CbGpPWpGaD
Aprindine—CALM2—Signaling by NGF—KIT—testicular cancer	0.000197	0.00268	CbGpPWpGaD
Aprindine—CALM1—Signaling by NGF—KIT—testicular cancer	0.000197	0.00268	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—KITLG—testicular cancer	0.00017	0.00232	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—KITLG—testicular cancer	0.000164	0.00224	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—KITLG—testicular cancer	0.000164	0.00224	CbGpPWpGaD
Aprindine—CALM3—Immune System—BCL10—testicular cancer	0.000164	0.00224	CbGpPWpGaD
Aprindine—CALM3—Adaptive Immune System—KITLG—testicular cancer	0.000163	0.00222	CbGpPWpGaD
Aprindine—CALM2—Immune System—BCL10—testicular cancer	0.000159	0.00216	CbGpPWpGaD
Aprindine—CALM1—Immune System—BCL10—testicular cancer	0.000159	0.00216	CbGpPWpGaD
Aprindine—CALM1—Adaptive Immune System—KITLG—testicular cancer	0.000158	0.00215	CbGpPWpGaD
Aprindine—CALM2—Adaptive Immune System—KITLG—testicular cancer	0.000158	0.00215	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—FGFR3—testicular cancer	0.000126	0.00172	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—FGFR3—testicular cancer	0.000122	0.00167	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—FGFR3—testicular cancer	0.000122	0.00167	CbGpPWpGaD
Aprindine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	0.000121	0.00165	CbGpPWpGaD
Aprindine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	0.000117	0.0016	CbGpPWpGaD
Aprindine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	0.000117	0.0016	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—KIT—testicular cancer	0.000116	0.00158	CbGpPWpGaD
Aprindine—CALM3—Metabolism—HPGDS—testicular cancer	0.000114	0.00155	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—KIT—testicular cancer	0.000112	0.00153	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—KIT—testicular cancer	0.000112	0.00153	CbGpPWpGaD
Aprindine—CALM3—Adaptive Immune System—KIT—testicular cancer	0.000111	0.00152	CbGpPWpGaD
Aprindine—CALM2—Metabolism—HPGDS—testicular cancer	0.00011	0.0015	CbGpPWpGaD
Aprindine—CALM1—Metabolism—HPGDS—testicular cancer	0.00011	0.0015	CbGpPWpGaD
Aprindine—CALM1—Adaptive Immune System—KIT—testicular cancer	0.000108	0.00147	CbGpPWpGaD
Aprindine—CALM2—Adaptive Immune System—KIT—testicular cancer	0.000108	0.00147	CbGpPWpGaD
Aprindine—CALM3—Disease—H2AFZ—testicular cancer	9.93e-05	0.00135	CbGpPWpGaD
Aprindine—CALM3—Immune System—KITLG—testicular cancer	9.9e-05	0.00135	CbGpPWpGaD
Aprindine—CALM2—Disease—H2AFZ—testicular cancer	9.61e-05	0.00131	CbGpPWpGaD
Aprindine—CALM1—Disease—H2AFZ—testicular cancer	9.61e-05	0.00131	CbGpPWpGaD
Aprindine—CALM2—Immune System—KITLG—testicular cancer	9.57e-05	0.00131	CbGpPWpGaD
Aprindine—CALM1—Immune System—KITLG—testicular cancer	9.57e-05	0.00131	CbGpPWpGaD
Aprindine—CALM3—Disease—KITLG—testicular cancer	9.14e-05	0.00125	CbGpPWpGaD
Aprindine—CALM1—Disease—KITLG—testicular cancer	8.84e-05	0.0012	CbGpPWpGaD
Aprindine—CALM2—Disease—KITLG—testicular cancer	8.84e-05	0.0012	CbGpPWpGaD
Aprindine—CALM3—Metabolism—STK11—testicular cancer	8.27e-05	0.00113	CbGpPWpGaD
Aprindine—CYP2D6—Metabolism—HPGDS—testicular cancer	8.13e-05	0.00111	CbGpPWpGaD
Aprindine—CALM1—Metabolism—STK11—testicular cancer	8e-05	0.00109	CbGpPWpGaD
Aprindine—CALM2—Metabolism—STK11—testicular cancer	8e-05	0.00109	CbGpPWpGaD
Aprindine—CALM3—Immune System—FGFR3—testicular cancer	7.36e-05	0.001	CbGpPWpGaD
Aprindine—CALM2—Immune System—FGFR3—testicular cancer	7.12e-05	0.00097	CbGpPWpGaD
Aprindine—CALM1—Immune System—FGFR3—testicular cancer	7.12e-05	0.00097	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	6.96e-05	0.000948	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—STK11—testicular cancer	6.92e-05	0.000943	CbGpPWpGaD
Aprindine—CALM3—Disease—FGFR3—testicular cancer	6.79e-05	0.000926	CbGpPWpGaD
Aprindine—CALM3—Immune System—KIT—testicular cancer	6.75e-05	0.000921	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	6.73e-05	0.000917	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	6.73e-05	0.000917	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—STK11—testicular cancer	6.69e-05	0.000912	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—STK11—testicular cancer	6.69e-05	0.000912	CbGpPWpGaD
Aprindine—CALM2—Disease—FGFR3—testicular cancer	6.57e-05	0.000896	CbGpPWpGaD
Aprindine—CALM1—Disease—FGFR3—testicular cancer	6.57e-05	0.000896	CbGpPWpGaD
Aprindine—CALM2—Immune System—KIT—testicular cancer	6.53e-05	0.000891	CbGpPWpGaD
Aprindine—CALM1—Immune System—KIT—testicular cancer	6.53e-05	0.000891	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—KITLG—testicular cancer	6.4e-05	0.000872	CbGpPWpGaD
Aprindine—CALM3—Disease—KIT—testicular cancer	6.24e-05	0.00085	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—KITLG—testicular cancer	6.19e-05	0.000844	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—KITLG—testicular cancer	6.19e-05	0.000844	CbGpPWpGaD
Aprindine—CALM2—Disease—KIT—testicular cancer	6.03e-05	0.000822	CbGpPWpGaD
Aprindine—CALM1—Disease—KIT—testicular cancer	6.03e-05	0.000822	CbGpPWpGaD
Aprindine—CYP2D6—Metabolism—STK11—testicular cancer	5.91e-05	0.000805	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—FGFR3—testicular cancer	4.76e-05	0.000648	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—FGFR3—testicular cancer	4.6e-05	0.000627	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—FGFR3—testicular cancer	4.6e-05	0.000627	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—KIT—testicular cancer	4.37e-05	0.000595	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—KIT—testicular cancer	4.22e-05	0.000576	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—KIT—testicular cancer	4.22e-05	0.000576	CbGpPWpGaD
